Rath Girija P, Prabhakar Hemanshu, Bithal Parmod K, Dash Hari H, Narang Karanjit S, Kalaivani M
Department of Neuroanesthesiology, All India Institute of Medical Sciences, New Delhi, India.
Middle East J Anaesthesiol. 2008 Jun;19(5):1041-53.
Subcutaneous tunneling for ventriculoperitoneal shunt insertion is the most painful step of this surgery. It is associated with intense hemodynamic response, may influence the intracranial pressure, and thus may worsen the existing intracranial pathology. The purpose of this report is to evaluate the commonly used opioid fentanyl, along with butorphanol, an agonist-antagonist compound.
Twenty adult patients undergoing ventriculoperitoneal shunt surgery were induced with fentanyl 2-mcg.kg(-1) and thiopentone 4-5 mg.kg(-1). Intubation followed the administration of rocuronium 1 mg.kg(-1). All patients were put on mechanical ventilation to maintain end-tidal carbon dioxide levels of 32 +/- 2 mmHg. Anesthesia was maintained with isoflurane in N2O and O2 (MAC 1.0 +/- 0.2). Routine monitoring, arterial blood pressure and intracranial pressures were measured. Three minutes prior to the tunneling phase, patients received either fentanyl 1 mcg.kg(-1) or butorphanol 1 mg in a randomized manner. Thereafter hemodynamic and intracranial pressure changes were noted during tunneling and each minute in the post-tunneling period for 5 minutes. The duration of the tunneling phase was also noted. Data were presented as number (proportion) or mean +/- SD/median (range) as appropriate. Statistical analysis was done using Wilkoxon ranksum test and the repeated measures of ANOVA. The value of p < 0.05 was considered significant.
A significant rise in the intracranial pressure and cerebral perfusion pressure along with the hemodynamic parameters was noted during the tunneling phase in both groups. The changes were of longer clinical duration in the butorphanol group.
Butorphanol must be used with caution in neurosurgical patients. The ventricular end of the shunt catheter should preferably be put before the tunneling phase to avoid rise in intracranial pressure.
脑室腹腔分流术皮下隧道造瘘是该手术中最疼痛的步骤。它会引发强烈的血流动力学反应,可能影响颅内压,进而可能使现有的颅内病变恶化。本报告的目的是评估常用的阿片类药物芬太尼以及激动 - 拮抗复合剂布托啡诺。
20例接受脑室腹腔分流术的成年患者,静脉注射芬太尼2μg/kg和硫喷妥钠4 - 5mg/kg进行诱导。注射罗库溴铵1mg/kg后进行气管插管。所有患者均进行机械通气,维持呼气末二氧化碳水平在32±2mmHg。采用异氟烷在氧化亚氮和氧气中维持麻醉(最低肺泡有效浓度1.0±0.2)。进行常规监测,测量动脉血压和颅内压。在隧道造瘘阶段前3分钟,患者随机接受芬太尼1μg/kg或布托啡诺1mg。此后,在隧道造瘘期间及造瘘后5分钟内每分钟记录血流动力学和颅内压变化。同时记录隧道造瘘阶段的持续时间。数据根据情况以数量(比例)或均值±标准差/中位数(范围)表示。采用威尔科克森秩和检验和重复测量方差分析进行统计分析。p < 0.05被认为具有统计学意义。
两组在隧道造瘘阶段均观察到颅内压、脑灌注压以及血流动力学参数显著升高。布托啡诺组的这些变化临床持续时间更长。
神经外科患者使用布托啡诺必须谨慎。分流导管的脑室端最好在隧道造瘘阶段之前放置,以避免颅内压升高。